Form D · Pharmaceuticals

Verseon Corp

Fremont, CA · CIK 0001348948

Offering snapshot reported Apr 24, 2019 · SEC filing

Reported sold
$101K
Offering amount: $101K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 18, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 24, 2019Initial$101,400No comparison1SEC filing
May 15, 2015Initial$451,000No comparison10SEC filing
May 15, 2015Initial$69,827No comparison5SEC filing
May 15, 2015Initial$259,573No comparison13SEC filing
May 15, 2015Initial$6,488,600No comparison22SEC filing
May 15, 2015Initial$11,808,858No comparison5SEC filing
May 14, 2015Initial$5,832,264No comparison28SEC filing
Dec 20, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-337994

Source: Form D, filed Apr 24, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eniko Fodor Director, Executive
Thomas Hecht Director
Sangtae Kim Director
David Kita Executive
Adityo Prakash Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
47071 Bayside Parkway
Fremont, CA, 94538